336 related articles for article (PubMed ID: 29454770)
21. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.
Audi S; Li Z; Capacete J; Liu Y; Fang W; Shu LG; Zhao M
Nucl Med Biol; 2012 Aug; 39(6):821-5. PubMed ID: 22534031
[TBL] [Abstract][Full Text] [Related]
22. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion.
Liu Z; Barrett HH; Stevenson GD; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Pak KY
J Nucl Med; 2004 Jul; 45(7):1251-9. PubMed ID: 15235074
[TBL] [Abstract][Full Text] [Related]
23. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.
Taki J; Higuchi T; Kawashima A; Fukuoka M; Kayano D; Tait JF; Matsunari I; Nakajima K; Kinuya S; Strauss HW
J Nucl Med; 2007 Aug; 48(8):1301-7. PubMed ID: 17631551
[TBL] [Abstract][Full Text] [Related]
24. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.
Johnson G; Okada CC; Hocherman SD; Liu Z; Hart C; Khaw BA; Okada RD
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):319-28. PubMed ID: 16237571
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
[TBL] [Abstract][Full Text] [Related]
26. Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.
Tekabe Y; Luma J; Li Q; Schmidt AM; Ramasamy R; Johnson LL
JACC Cardiovasc Imaging; 2012 Jan; 5(1):59-67. PubMed ID: 22239894
[TBL] [Abstract][Full Text] [Related]
27. [
Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y
Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197
[TBL] [Abstract][Full Text] [Related]
28. Imaging acute cardiac cell death: temporal and spatial distribution of 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion.
Zhu X; Li Z; Zhao M
J Nucl Med; 2007 Jun; 48(6):1031-6. PubMed ID: 17536109
[TBL] [Abstract][Full Text] [Related]
29. Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V.
Mari C; Karabiyikoglu M; Goris ML; Tait JF; Yenari MA; Blankenberg FG
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):733-9. PubMed ID: 14985868
[TBL] [Abstract][Full Text] [Related]
30. Monitoring apoptosis in real time.
Green AM; Steinmetz ND
Cancer J; 2002; 8(2):82-92. PubMed ID: 11999952
[TBL] [Abstract][Full Text] [Related]
31. (99m)Tc-Annexin-V uptake in a rat model of variable ischemic severity and reperfusion time.
Taki J; Higuchi T; Kawashima A; Tait JF; Muramori A; Matsunari I; Nakajima K; Vanderheyden JL; Strauss HW
Circ J; 2007 Jul; 71(7):1141-6. PubMed ID: 17587725
[TBL] [Abstract][Full Text] [Related]
32. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.
Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L
J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.
Tanimoto T; Parseghian MH; Nakahara T; Kawai H; Narula N; Kim D; Nishimura R; Weisbart RH; Chan G; Richieri RA; Haider N; Chaudhry F; Reynolds GT; Billimek J; Blankenberg FG; Sengupta PP; Petrov AD; Akasaka T; Strauss HW; Narula J
J Am Coll Cardiol; 2017 Sep; 70(12):1479-1492. PubMed ID: 28911512
[TBL] [Abstract][Full Text] [Related]
34. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
[TBL] [Abstract][Full Text] [Related]
36. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
[TBL] [Abstract][Full Text] [Related]
37. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.
Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Okada RD
J Nucl Med; 2004 Apr; 45(4):655-64. PubMed ID: 15073263
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia.
Tang XN; Wang Q; Koike MA; Cheng D; Goris ML; Blankenberg FG; Yenari MA
J Nucl Med; 2007 Nov; 48(11):1822-8. PubMed ID: 17942809
[TBL] [Abstract][Full Text] [Related]
39. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
Tokita N; Hasegawa S; Maruyama K; Izumi T; Blankenberg FG; Tait JF; Strauss HW; Nishimura T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
[TBL] [Abstract][Full Text] [Related]
40.
Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
